ARTICLE | Company News
Insmed Pharmaceuticals, Taisho deal
March 20, 2000 8:00 AM UTC
Insmed signed a letter of intent to grant Taisho exclusive development and commercialization rights to Insmed's INS-1 compound in Japan and other Asian countries. Insmed will retain rights to INS-1 in...